STOCK TITAN

[SCHEDULE 13G/A] eHealth, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Goldman Sachs reports beneficial ownership of 767,063.28 shares of eHealth common stock, representing 2.5% of the outstanding class. The filing shows no sole voting or dispositive power and records shared voting power of 766,913.28 shares and shared dispositive power of 767,063.28 shares, indicating control of these shares is exercised jointly rather than individually. The Schedule 13G/A states the holdings are held in the ordinary course of business and not for the purpose of changing or influencing control. A joint filing agreement and an exhibit identifying Goldman Sachs & Co. LLC as the relevant subsidiary are attached.

Goldman Sachs dichiara la titolarità beneficiaria di 767.063,28 azioni ordinarie di eHealth, pari al 2,5% della classe in circolazione. La denuncia indica assenza di potere di voto o di disposizione in via esclusiva e registra potere di voto condiviso su 766.913,28 azioni e potere di disposizione condiviso su 767.063,28 azioni, a indicare che il controllo di queste azioni è esercitato congiuntamente e non individualmente. Il Schedule 13G/A specifica che le partecipazioni sono detenute nell'ordinario svolgimento dell'attività e non con l'intento di modificare o influenzare il controllo. Sono allegati un accordo di presentazione congiunta e un documento che identifica Goldman Sachs & Co. LLC come la controllata rilevante.

Goldman Sachs declara la titularidad beneficiaria de 767.063,28 acciones ordinarias de eHealth, que representan el 2,5% de la clase en circulación. El informe muestra ausencia de poder de voto ni de disposición en exclusiva y registra poder de voto compartido sobre 766.913,28 acciones y poder de disposición compartido sobre 767.063,28 acciones, lo que indica que el control de estas acciones se ejerce conjuntamente y no de forma individual. El Schedule 13G/A establece que las participaciones se mantienen en el curso normal del negocio y no con la intención de cambiar o influir en el control. Se adjunta un acuerdo de presentación conjunta y un anexo que identifica a Goldman Sachs & Co. LLC como la filial relevante.

골드만 삭스는 eHealth 보통주의 실소유 지분 767,063.28주(발행 주식의 2.5%)를 보유하고 있다고 보고했습니다. 제출 문서에는 단독 의결권 또는 단독 처분권이 없음으로 기재되어 있으며 의결권 공동 보유 766,913.28주처분권 공동 보유 767,063.28주로 기록되어 있어 해당 주식에 대한 통제권이 개별적으로가 아니라 공동으로 행사되고 있음을 나타냅니다. Schedule 13G/A에는 이 보유가 통상적인 영업 과정에서 보유된 것이며 지배권을 변경하거나 영향력을 행사할 목적으로 보유된 것이 아님이 명시되어 있습니다. 공동 제출 계약서와 Goldman Sachs & Co. LLC를 관련 자회사로 특정하는 증빙 서류가 첨부되어 있습니다.

Goldman Sachs déclare être le propriétaire bénéficiaire de 767 063,28 actions ordinaires d'eHealth, représentant 2,5 % de la classe en circulation. Le dépôt indique l'absence de pouvoir de vote ou de disposition exclusif et mentionne pouvoir de vote partagé sur 766 913,28 actions et pouvoir de disposition partagé sur 767 063,28 actions, ce qui indique que le contrôle de ces actions est exercé conjointement plutôt qu'individuellement. Le Schedule 13G/A stipule que les participations sont détenues dans le cadre normal des activités et non dans le but de modifier ou d'influencer le contrôle. Un accord de dépôt conjoint et une pièce justificative identifiant Goldman Sachs & Co. LLC comme la filiale concernée sont annexés.

Goldman Sachs meldet wirtschaftliches Eigentum an 767.063,28 Aktien der Stammaktien von eHealth, was 2,5 % der ausstehenden Klasse entspricht. Die Einreichung weist keine alleinige Stimm- oder Verfügungsbefugnis aus und verzeichnet gemeinsame Stimmrechte über 766.913,28 Aktien sowie gemeinsame Verfügungsrechte über 767.063,28 Aktien, was darauf hindeutet, dass die Kontrolle über diese Aktien gemeinsam und nicht einzeln ausgeübt wird. Das Schedule 13G/A gibt an, dass die Bestände im ordentlichen Geschäftsverlauf gehalten werden und nicht mit der Absicht, die Kontrolle zu verändern oder zu beeinflussen. Ein gemeinsamer Einreichungsvertrag sowie ein Anhang, der Goldman Sachs & Co. LLC als relevante Tochtergesellschaft identifiziert, sind beigefügt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: This is a routine disclosure: Goldman Sachs group reports a modest, non-controlling 2.5% stake in eHealth with shared voting/dispositive powers.

The Schedule 13G/A shows an aggregate beneficial position of 767,063.28 shares (2.5%) held by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC with no sole voting or dispositive power. The form's certification that the shares are held in the ordinary course and not to influence control, together with the joint filing agreement and subsidiary identification exhibit, support a passive reporting posture. For investors, this filing documents ownership concentration but does not indicate an activist intent or control change.

TL;DR: Governance impact is minimal: shared powers and a passive declaration signal no immediate change in board influence from this stake.

The filing differentiates between the parent holding company and its broker-dealer/ adviser subsidiary and attaches an exhibit clarifying that Goldman Sachs & Co. LLC is the operating subsidiary. Reported shared voting power (766,913.28) and shared dispositive power (767,063.28) imply consolidated reporting rather than unilateral control. The explicit certification that holdings were not acquired to affect control further reduces governance risk from this disclosure.

Goldman Sachs dichiara la titolarità beneficiaria di 767.063,28 azioni ordinarie di eHealth, pari al 2,5% della classe in circolazione. La denuncia indica assenza di potere di voto o di disposizione in via esclusiva e registra potere di voto condiviso su 766.913,28 azioni e potere di disposizione condiviso su 767.063,28 azioni, a indicare che il controllo di queste azioni è esercitato congiuntamente e non individualmente. Il Schedule 13G/A specifica che le partecipazioni sono detenute nell'ordinario svolgimento dell'attività e non con l'intento di modificare o influenzare il controllo. Sono allegati un accordo di presentazione congiunta e un documento che identifica Goldman Sachs & Co. LLC come la controllata rilevante.

Goldman Sachs declara la titularidad beneficiaria de 767.063,28 acciones ordinarias de eHealth, que representan el 2,5% de la clase en circulación. El informe muestra ausencia de poder de voto ni de disposición en exclusiva y registra poder de voto compartido sobre 766.913,28 acciones y poder de disposición compartido sobre 767.063,28 acciones, lo que indica que el control de estas acciones se ejerce conjuntamente y no de forma individual. El Schedule 13G/A establece que las participaciones se mantienen en el curso normal del negocio y no con la intención de cambiar o influir en el control. Se adjunta un acuerdo de presentación conjunta y un anexo que identifica a Goldman Sachs & Co. LLC como la filial relevante.

골드만 삭스는 eHealth 보통주의 실소유 지분 767,063.28주(발행 주식의 2.5%)를 보유하고 있다고 보고했습니다. 제출 문서에는 단독 의결권 또는 단독 처분권이 없음으로 기재되어 있으며 의결권 공동 보유 766,913.28주처분권 공동 보유 767,063.28주로 기록되어 있어 해당 주식에 대한 통제권이 개별적으로가 아니라 공동으로 행사되고 있음을 나타냅니다. Schedule 13G/A에는 이 보유가 통상적인 영업 과정에서 보유된 것이며 지배권을 변경하거나 영향력을 행사할 목적으로 보유된 것이 아님이 명시되어 있습니다. 공동 제출 계약서와 Goldman Sachs & Co. LLC를 관련 자회사로 특정하는 증빙 서류가 첨부되어 있습니다.

Goldman Sachs déclare être le propriétaire bénéficiaire de 767 063,28 actions ordinaires d'eHealth, représentant 2,5 % de la classe en circulation. Le dépôt indique l'absence de pouvoir de vote ou de disposition exclusif et mentionne pouvoir de vote partagé sur 766 913,28 actions et pouvoir de disposition partagé sur 767 063,28 actions, ce qui indique que le contrôle de ces actions est exercé conjointement plutôt qu'individuellement. Le Schedule 13G/A stipule que les participations sont détenues dans le cadre normal des activités et non dans le but de modifier ou d'influencer le contrôle. Un accord de dépôt conjoint et une pièce justificative identifiant Goldman Sachs & Co. LLC comme la filiale concernée sont annexés.

Goldman Sachs meldet wirtschaftliches Eigentum an 767.063,28 Aktien der Stammaktien von eHealth, was 2,5 % der ausstehenden Klasse entspricht. Die Einreichung weist keine alleinige Stimm- oder Verfügungsbefugnis aus und verzeichnet gemeinsame Stimmrechte über 766.913,28 Aktien sowie gemeinsame Verfügungsrechte über 767.063,28 Aktien, was darauf hindeutet, dass die Kontrolle über diese Aktien gemeinsam und nicht einzeln ausgeübt wird. Das Schedule 13G/A gibt an, dass die Bestände im ordentlichen Geschäftsverlauf gehalten werden und nicht mit der Absicht, die Kontrolle zu verändern oder zu beeinflussen. Ein gemeinsamer Einreichungsvertrag sowie ein Anhang, der Goldman Sachs & Co. LLC als relevante Tochtergesellschaft identifiziert, sind beigefügt.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



THE GOLDMAN SACHS GROUP, INC.
Signature:Name: Mariana Audeves Martinez
Name/Title:Attorney-in-fact
Date:07/17/2025
GOLDMAN SACHS & CO. LLC
Signature:Name: Mariana Audeves Martinez
Name/Title:Attorney-in-fact
Date:07/17/2025
Exhibit Information

EXHIBIT (99.1) JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, par value $0.001 per share, of EHEALTH, INC. and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G. Date: 07/17/2025 THE GOLDMAN SACHS GROUP, INC. By:/s/ Mariana Audeves Martinez ---------------------------------------- Name: Mariana Audeves Martinez Title: Attorney-in-fact GOLDMAN SACHS & CO. LLC By:/s/ Mariana Audeves Martinez ---------------------------------------- Name: Mariana Audeves Martinez Title: Attorney-in-fact EXHIBIT (99.2) ITEM 7 INFORMATION The securities being reported on by The Goldman Sachs Group, Inc. ("GS Group"), as a parent holding company, are owned, or may be deemed to be beneficially owned, by Goldman Sachs & Co. LLC ("Goldman Sachs"), a broker or dealer registered under Section 15 of the Act and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940. Goldman Sachs is a subsidiary of GS Group.

FAQ

What stake does Goldman Sachs report in eHealth (EHTH)?

The filing reports an aggregate beneficial ownership of 767,063.28 shares, representing 2.5% of eHealth's common stock.

Does Goldman Sachs have sole voting or dispositive power over EHTH shares?

No. The filing states 0.00 shares as sole voting power and sole dispositive power; voting and dispositive powers are reported as shared.

What are the shared voting and dispositive power amounts reported?

The Schedule shows shared voting power of 766,913.28 shares and shared dispositive power of 767,063.28 shares.

Is this filing consistent with passive ownership or an attempt to influence control?

The certification in Item 10 states the securities are held in the ordinary course of business and were not acquired to change or influence control, indicating passive ownership.

Which Goldman Sachs entities are named in the Schedule 13G/A for EHTH?

The filing lists The Goldman Sachs Group, Inc. (parent) and Goldman Sachs & Co. LLC (subsidiary broker/dealer and investment adviser).
Ehealth Inc

NASDAQ:EHTH

EHTH Rankings

EHTH Latest News

EHTH Latest SEC Filings

EHTH Stock Data

105.73M
28.42M
5.83%
74.14%
3.55%
Insurance Brokers
Insurance Agents, Brokers & Service
Link
United States
AUSTIN